Nuvation Bio Inc. (NUVB)
NYSE: NUVB
· Real-Time Price · USD
2.10
0.06 (2.94%)
At close: May 08, 2025, 3:59 PM
2.13
1.18%
After-hours: May 08, 2025, 07:37 PM EDT
2.94% (1D)
| Bid | 2.05 |
| Market Cap | 712.9M |
| Revenue (ttm) | 7.87M |
| Net Income (ttm) | -567.94M |
| EPS (ttm) | -2.11 |
| PE Ratio (ttm) | -1 |
| Forward PE | -3.26 |
| Analyst | Buy |
| Ask | 2.19 |
| Volume | 3,685,493 |
| Avg. Volume (20D) | 2,888,311 |
| Open | 2.22 |
| Previous Close | 2.04 |
| Day's Range | 1.98 - 2.30 |
| 52-Week Range | 1.54 - 3.97 |
| Beta | 1.42 |
About NUVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUVB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUVB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Nuvation Bio has released their quartely earnings
on May 7, 2025:
4 months ago
+14.44%
Nuvation Bio shares are trading higher after RBC C...
Unlock content with
Pro Subscription
9 months ago
-5.36%
Nuvation Bio shares are trading lower. The company reported Q2 financial results.
2 months ago · businesswire.com
Nuvation Bio to Present at the TD Cowen 45th Annual Health Care ConferenceNEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, Pre...